Hinge Health利用软件在很大程度上实现了关节和肌肉健康护理的自动化。该公司设计的平台旨在解决广泛的肌肉骨骼 (MSK) 护理问题,包括急性损伤、慢性疼痛和术后康复。为了实现护理自动化,Hinge开发了人工智能运动追踪技术 (TrueMotion)、经FDA批准的专有可穿戴设备(Enso)以及人工智能支持的护理团队,以提供可扩展和个性化的MSK护理。
Hinge Health成立于2012年,截至2025年3月31日的12个月营收为4.32亿美元。该公司计划在纽约证交所上市,股票代码为“HNGE”。摩根士丹利、巴克莱、美国银行证券、Evercore ISI等是此次交易的联合簿记行。预计该公司将于2025年5月19日当周定价。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.